Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer
J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Association between Guillain-Barr� Syndrome and Influenza a (H1N1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis
Lancet 381:1461-1468, Salmon, D.,et al, 2013
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
Postvaccination Miller Fisher Syndrome
Arch Neurol 68:1325-1327, Shoamanesh, A.,et al, 2011
Guillain-Barre Syndrome Follwoing Influenza Vaccination
JAMA 292:2478-2481, Haber,P.,et al, 2004
Secondary Hyperkalaemic Paralysis
JNNP 64:249-252, Evers,S.,et al, 1998
An Acute Neurologic Syndrome Temporally Associated with Postexposure Trtm of Rabies
Pediatrics 100:720-721, Mortiere,M.D.&Falcone,A.L., 1997
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Epidemiology of Guillain-Barre Syndrome in Children:Relationship of Oral Polio Vaccine Administration to Occurrence
J Pediatr 124:220-223, Rantala,H.,et al, 1994
Guillain-Barre Syndrome after Exogenous Gangliosides in Italy
BMJ 307:1463-1464, Landi,G.,et al, 1993
Bovine Gangliosides and Acute Motor Polyneuropathy
BMJ 305:1330-1331, Figueras,A.,et al, 1992
Eosinophilia-Myalgia Syndrome-New Mexico
JAMA 262:3116, Belvins,W.L.,et al, 1989
Incidence of Guillain-Barre Syndrome During a Nationwide Oral Poliovirus Vaccine Campaign
Neurol 39:1034-1036, Kinnumen,E.,et al, 1989
Guillain-Barre Syndrome & Influenza Vaccine
BMJ p. 1371, May 28977., , 1977
A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025
Atypical Diabetic Neuropathies
BMJ 390:e081109, McCray,B.A.,et al, 2025
Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023
Intracerebral Haemorrhage Caused by Iatrogenic Cerebral Amyloid Angiopathy in a Patient with a History of Neurosurgery 35 Years Earlier
Lancet 402:11, Fandler-Hofler,et al, 2023
Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023
Surgical Treatment of Atrioesophageal Fistula:A Systematic Review
Ann Thorac Surg 116:421-428, Amirkhosravi,F.,et al, 2023
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
A 62-year-old man with history of catheter ablation presenting with recurrent strokes
Neurol 95:e3065-e3069, Jeanneret, V.,et al, 2020
Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018
Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Candida Infections of the Central Nervous System
UptoDate Jan, Kauffman, C.A., 2016
Anticoagulants for Cerebral Venous Thrombosis
Stroke 45:298-304,8, Cundiff, D.K., 2014
Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013
Aspergillus Meningitis: A Rare Clinical Manifestation of Central Nervous System Aspergillosis
J Infect 66:218-238, Antinori, S.,et al, 2013
Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
J Natl Cancer Inst 101:946-958, Armstrong,G.T.,et al, 2009
Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients
AJNR 29:781-785, Suh,D.C.,et al, 2008
4-Aminopyridine Toxicity with Unintentional Overdose in Four Patients with Multiple Sclerosis
Neurol 71:1833-1834, Burton,J.M.,et al, 2008
Investigating the Hoarse Voice
BMJ 337:1165-1168, Pretorius,P.M. &Milford,C.A., 2008
Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Posttraumatic Headache-A Myth?
Arch Neurol 57:1778-1780, Warner,J.S., 2000
Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999
Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999
Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998
Intractable Partial Epilepsy Following Low-Dose Scalp Irradiation in Infnacy
Ann Neurol 38:951-954, Reutens,D.C.,et al, 1995
Intracerebral Hemorrhage After Fibrinolytic Therapy for Acute Myocardial Infarction
C. R. , Stroke 24:554-557, 5233., Wijdicks,E.F.M.&Jack,Jr, 1993
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Stridor:Intracranial pathology Causing Postextubation Vocal Cord Paralysis
Pediatrics 87:39-43, Chaten,F.C.,et al, 1991
Neuropsychiatric Aspects of Psychogenic Status Epilepticus
Neurol 41:1104-1106, Pakainis,A.,et al, 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990
Risks Associated with Giving Benzodiazepines to Patients with Acute Neurological Injuries
BMJ 300:1189-1190, Eldridge,P.R.&Punt,J.A.G., 1990